Watchlist Price Alert

Lixte Biotechnology Inc. (LIXT)

NASDAQ: LIXT · Real-Time Price · USD

0.83

0.04 (5.38%)

At close: Jun 24, 2025, 3:59 PM

0.83

-0.40%

Pre-market: Jun 25, 2025, 07:01 AM EDT

Lixte Biotechnology Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-3.59M	-5.09M	-6.31M	-6.73M	-3.26M	-2.44M	-2.13M	-1.81M	-2.13M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	418.42K	773.2K	1.55M	2.6M	1.25M	748.65K	785.61K	70.69K	287.16K
Other Working Capital	3.01K	94.54K	150.96K	-49.11K	-164.62K	69.2K	-46.7K	173.1K	-65.51K
Other Non-Cash Items	418.42K	n/a	1.54M	2.56M	1.19M	814.68K	902.43K	-81.74K	87.16K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	3.01K	20.56K	154.76K	-13.44K	-117.88K	17.54K	-163.52K	325.54K	170.13K
Operating Cash Flow	-3.16M	-4.29M	-4.61M	-4.14M	-2.13M	-1.67M	-1.51M	-1.41M	-1.68M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	5.14M	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	3.14M	n/a	n/a	n/a	n/a	n/a	n/a	104.09K
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	104.09
Investing Cash Flow	n/a	n/a	5.14M	n/a	n/a	n/a	n/a	n/a	104.09K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2K
Other Financial Acitivies	n/a	6.32K	n/a	207.63K	n/a	n/a	-21.7K	18K	n/a
Financial Cash Flow	n/a	3.14M	5.14M	3.9M	4.6M	n/a	4.48M	2.52M	1.75M
Net Cash Flow	-3.16M	-1.15M	529.65K	-245.52K	2.47M	-1.67M	2.97M	1.11M	174.65K
Free Cash Flow	-3.16M	-4.29M	-4.61M	-4.14M	-2.13M	-1.67M	-1.51M	-1.41M	-1.68M